AVTX

Avalo Therapeutics Inc. Common Stock (AVTX)

Stock · NASDAQ · Health Care

$19.59as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$13.5
Industry
Biotechnology: Pharmaceutical Preparations

Avalo Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • AVTX
    Avalo Therapeutics Inc. Common Stock
    $19.59
    ▼ 2.29%
    Market cap $954.90MP/E
  • JANX
    Janux Therapeutics Inc. Common Stock
    $18.01
    ▼ 4.10%
    Market cap $934.28MP/E
    $12.12$35.34
  • OLMA
    Olema Pharmaceuticals Inc. Common Stock
    $10.28
    ▼ 4.77%
    Market cap $985.28MP/E
    $5.36$36.26
  • OMER
    Omeros Corporation Common Stock
    $18.59
    ▼ 3.43%
    Market cap $909.03MP/E 14.37
    $3.94$19.65
  • IVA
    Inventiva S.A. American Depository Shares
    $4.71
    ▼ 3.98%
    Market cap $1.00BP/E
    $2.88$6.2
  • AMPH
    Amphastar Pharmaceuticals Inc. Common Stock
    $22.01
    ▲ 0.59%
    Market cap $891.56MP/E 10.93
    $16.65$31.26
  • LXRX
    Lexicon Pharmaceuticals Inc. Common Stock
    $2.29
    ▼ 1.29%
    Market cap $1.03BP/E
    $1.03$2.68

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
33.98M
Total value held
$474.34M
Institutional holders
97
Top holders this quarter
  • Unknown2.88M
  • Unknown2.16M
  • Unknown1.64M
  • Unknown1.63M
  • Unknown1.41M
  • Unknown1.34M
  • Unknown1.30M
  • Unknown1.24M
  • Unknown1.14M
  • Unknown1.09M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.